This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnering Summit
May 17-19, 2022
Delivered as a Hybrid EventBoston, MA

Martine Zimmermann
Global Head of Regulatory Affairs at Alexion Pharmaceuticals

Agenda Sessions

  • Compare Global Regulatory and Commercial Pathways for Orphan Drugs

  • Risks and Rewards of Rare Disease Drug Development — Highlight Opportunities and the Way Forward


Speakers at this event